A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/485 (2006.01) A61K 9/20 (2006.01) A61K 31/137 (2006.01) A61K 31/444 (2006.01) A61K 45/06 (2006.01)
Patent
CA 2486075
The present invention pertains to a solid dosage form comprising an analgesically effective amount of opioid analgesic and an opioid abuse- deterring amount of a nontoxic N-methyl-D-aspartate receptor antagonist contained in a carrier which isolates, or separates, the antagonist from the opioid analgesic. The nontoxic N-methyl-D-aspartate receptor antagonist is released and made available only when the dosage form is misused, as would be the case when the dosage form is crushed or dissolved and thereafter administered in a manner other than that indicated, e.g., by injection or intranasally.
L'invention concerne une forme pharmaceutique solide renfermant une quantité analgésique efficace d'analgésique opioïde et une quantité d'antagoniste vis-à-vis du récepteur de N-méthyl-D-aspartate, non toxique, qui permet d'éviter les abus d'opioïdes, contenue dans un vecteur qui isole ou sépare l'antagoniste de l'analgésique opioïde. Cet antagoniste est libéré et rendu utilisable uniquement lorsque la forme pharmaceutique fait l'objet d'une utilisation abusive, à savoir par exemple broyage ou dissolution puis administration s'écartant des instructions fournies, du type injection ou administration intranasale.
Galer Bradley
Kao Huaihung D.
Kerr David
Endo Pharmaceuticals Inc.
Mcfadden Fincham
LandOfFree
Abuse-resistant opioid solid dosage form does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Abuse-resistant opioid solid dosage form, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Abuse-resistant opioid solid dosage form will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1956412